Kidney Diseases: all 3,842 studies
Page 30 of 39. Open to participants first (491), then studies with results posted, then the rest; newest registration first within each.
- Effects of High Dietary Fiber Supplementation in Diabetic Chronic Kidney DiseaseCompletedNCT01838330Not applicable
- Development of a Metabolic Assessment Tool for Chronic Kidney DiseaseCompletedNCT01838239Not applicable
- Efficacy of Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation in Hemodialysis PatientsCompletedNCT01837238Not applicable
- Differential Effects of Ergocalciferol and Cholecalciferol Therapies in Chronic Kidney DiseaseCompletedNCT01835691Not applicable
- Renal Denervation in Patients With Chronic Kidney DiseaseCompletedNCT01832233Not applicable
- Effect of Oral Supplementation With Curcumin (Turmeric) in Patients With Proteinuric Chronic Kidney DiseaseCompletedNCT01831193Phase 3
- Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD)CompletedNCT01829256Not applicable
- RAS Quantification in Patients With Aliskiren or CandesartanCompletedNCT01827202Phase 4
- Oral Calcitriol for Reduction of Mild Proteinuria in Patients With CKDStatus unknownNCT01820832Phase 4
- Paricalcitol Over Inflammatory Parameters on Chronical Kidney Disease PatientsCompletedNCT01820767Phase 3
- N-Acetyl Cystein and Contrast NephropathyStatus unknownNCT01820195Phase 3
- Paricalcitol on Albuminuria, Inflammation and Fibrosis on Proteinuric Chronic Renal Diseases (PALIFE Study)TerminatedNCT01820078Phase 4
- Long-term Extension Study of MCI-196TerminatedNCT01814917Phase 3
- Dose-finding Study of MCI-196TerminatedNCT01814904Phase 3
- Comparison of Body Hydration State in Hemodialysis PatientsTerminatedNCT01814254
- Sex-specific Association With Kidney DiseaseCompletedNCT01810822
- A New Diet for Patients With Autosomal Dominant Polycystic Disease (ADPKD)CompletedNCT01810614Not applicable
- Study of Safety and Tolerability of BPS804 in Patients With Late-stage Chronic Kidney DiseaseWithdrawnNCT01806610Phase 2
- RAS Blockade at Bedtime Versus on Awakening for Aldosterone BreakthroughCompletedNCT01805362Not applicable
- Study on Single-nucleotide-polymorphism in Idiopathic Membranous NephropathyStatus unknownNCT01799460
- Beraprost Sodium and Arterial Stiffness in Patients With Type 2 Diabetic NephropathyStatus unknownNCT01796418Not applicable
- Navigating the Challenges of Chronic Kidney DiseaseCompletedNCT01792661Not applicable
- Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Type 2 Diabetes And Chronic Kidney DiseaseStatus unknownNCT01792206Not applicable
- Preventing Contrast-induced Nephropathy: Evaluating Hydration Strategies and L-carnitine AdministrationTerminatedNCT01786824Phase 3
- House Calls and Decision Support: Improving Access to Live Donor TransplantationCompletedNCT01786525Not applicable
- The Impact Of Periodontal Disease Treatment On The General Health Status In Chronic Haemodialyzed PatientsStatus unknownNCT01785355
- Probiotics in IgA NephropathyStatus unknownNCT01781312Not applicable
- Minocycline and Proteinuria in Diabetic NephropathyStatus unknownNCT01779089Not applicable
- Comparing Effects of Patient-specific Versus Non-patient-specific Computerized Reminder SystemStatus unknownNCT01778140Not applicable
- Comparison of Standard Versus Low Bicarbonate HemodialysisCompletedNCT01777178Phase 1
- IgA Nephropathy, Lymphocyte Homing and IgA Class SwitchCompletedNCT01775527Not applicable
- Advanced Glycation End-products, Inflammation and Vascular Health in Chronic Kidney DiseaseCompletedNCT01769963Not applicable
- PINOT Follow-up Study in End-stage Kidney DiseaseCompletedNCT01768624
- SLC2A1 Variants and Diabetic NephropathyCompletedNCT01768611
- Paricalcitol Effect on Anemia in CKDCompletedNCT01768351Phase 4
- Improving Evidence-Based Primary Care for Chronic Kidney DiseaseCompletedNCT01767883Not applicable
- Impact of Increased Water Intake in Chronic Kidney DiseaseCompletedNCT01766687Not applicable
- Electroacupuncture for Hypertension Patients With Chronic Kidney DiseaseCompletedNCT01766427
- Study of the Effect of Synchronised Anaemia Management in Chronic Kidney DiseaseCompletedNCT01763242Phase 4
- Limb Ischemic Preconditioning for Prevention of Contrast Media Induced Nephropathy in Diabetic Kidney PatientStatus unknownNCT01763034Not applicable
- Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous NephropathyWithdrawnNCT01762852Phase 2
- The Role of Peritoneal Dialysis in Patients With Refractory Heart Failure and Chronic Kidney DiseaseCompletedNCT01758627Not applicable
- Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA NephropathyStatus unknownNCT01758120Phase 4
- A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFRCompletedNCT01756716Phase 2
- A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With AlbuminuriaCompletedNCT01756703Phase 2
- A Study to Assess Hemoglobin Level Depending on the Comorbidity Index in Chronic Kidney Disease (CKD) Participants Not in Dialysis Treated With Methoxy Polyethylene Glycol-Epoetin Beta (COMETE)CompletedNCT01756612
- The Water Intake Trial: Pilot PhaseCompletedNCT01753466Phase 3
- Effect of Phosphate Binders on FGF-23 With Concurrent CalcitriolCompletedNCT01748396Phase 4
- Renal Denervation for Treatment of Resistant Hypertension in Patients With Chronic Kidney DiseaseNo longer availableNCT01747382
- Evaluation of the Safety and Efficacy of a Vascular Prosthesis for Hemodialysis Access in Patients With ESRDCompletedNCT01744418Not applicable
- Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic NephropathyStatus unknownNCT01743014Phase 4
- Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on DialysisCompletedNCT01742611Phase 3
- A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on DialysisCompletedNCT01742585Phase 3
- Can Remote Ischaemic Preconditioning Reduce Contrast Induced Nephropathy in Patients Receiving Contrast for Computed Tomography?CompletedNCT01741896Not applicable
- Study to Assess Pegloticase (KRYSTEXXA®) in Patients on HemodialysisCompletedNCT01739660Phase 1
- The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal DiseaseCompletedNCT01738035Phase 2
- Renal Sympathetic Denervation in Patients With Chronic Kidney Disease and Resistant HypertensionStatus unknownNCT01737138Not applicable
- Dose-Titration Study of Sevelamer Carbonate in Chronic Kidney Disease (CKD) Patients on HemodialysisCompletedNCT01736150Phase 3
- Role of Prohepcidin in Uremic PatientsCompletedNCT01735773
- A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD)Status unknownNCT01731301Phase 4
- Arterial Wall Calcium Load in Pseudoxanthoma ElasticumStatus unknownNCT01731080
- Efficacy and Safety Study of Probucol in Patients With Diabetic NephropathyCompletedNCT01726816Phase 2
- Efficacy and Safety of Alprostadil Prevent Contrast Induced NephropathyStatus unknownNCT01722513Phase 4
- What Are the Determinations of Adult Progressive CKD? The Renal Impairment In Secondary Care (RIISC) StudyActive, not recruitingNCT01722383
- Prospective Observational Study of Erythropoietin-Iron Interaction in Anemia of Renal DiseaseCompletedNCT01719146
- Safety Study of GCS-100 to Treat Chronic Kidney DiseaseCompletedNCT01717248Phase 1
- Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease PatientsStatus unknownNCT01709994Phase 3
- Local Anaesthesia vs Regional Block for Arteriovenous FistulaeStatus unknownNCT01706354Not applicable
- Urinary Biomarkers of the Progression of Alport Kidney DiseaseCompletedNCT01705132
- FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric PatientsCompletedNCT01703234Phase 4
- Serum Omentin-1 and Carotid Atherosclerosis In Non-Diabetic Chronic Kidney DiseaseStatus unknownNCT01701830
- Clinical Efficacy of Two Erythropoietin Drug in Participants With Secondary Anemia to Chronic Kidney Disease.TerminatedNCT01695759Phase 3
- Pseudoexfoliation and Chronic Kidney DiseaseCompletedNCT01693744
- Inflammation in Peritoneal Dialysis Patients: Effect of ObesityWithdrawnNCT01691196
- Mineralocorticoid Receptor Antagonists in End Stage Renal DiseaseCompletedNCT01691053Phase 2
- Surveillance and Follow-up for Latent Tuberculosis Infection and Observation of the Effect of Prophylactic Latent Tuberculosis Treatment in Patients With Severe Chronic Kidney Disease or Receiving Long-term DialysisStatus unknownNCT01685086
- Effect of An Oral Absorbent AST-120 in Late-stage Chronic Kidney Disease (CKD) Patients.CompletedNCT01681303Phase 4
- Sirolimus for Massive Polycystic LiverStatus unknownNCT01680250Phase 2/3
- Paricalcitol and Endothelial Function in Chronic Kidney Disease Patients (the PENNY Study)CompletedNCT01680198Phase 3
- Dose Escalation Study to Investigate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BAY85-3934 in Subjects With Chronic Kidney Disease (CKD)CompletedNCT01679587Phase 1
- Blood Volume Analysis and Related Outcomes in HemodialysisCompletedNCT01679249
- Pharmacokinetic Comparison of Vitamin's D2 and D3 in Stage 5 Chronic Kidney Disease Patients on Chronic HemodialysisCompletedNCT01675557Phase 4
- Role of Nox2 in CNI-induced Renal FibrosisCompletedNCT01674465
- Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic NephropathyStatus unknownNCT01673204Phase 4
- Effect of Vitamin D Supplementation on Coronary Calcification and Parathyroid Hormone in CKD PatientsStatus unknownNCT01672047Not applicable
- Very Low Calorie Diet for Diabetic Kidney DiseaseCompletedNCT01671969Not applicable
- Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney DiseaseWithdrawnNCT01668901Phase 4
- Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood PressureCompletedNCT01667614Phase 2
- Sleep Disorders in Pediatric DialysisCompletedNCT01667588
- A Study to Assess the Pharmacokinetics of Ceftaroline in End Stage Renal Disease Patients and Matched Healthy SubjectsCompletedNCT01664065Phase 1
- Randomised Control Trial for Improving Functional Outcome From Stroke in End Stage Renal Disease PatientsCompletedNCT01656213Not applicable
- In Vivo Evaluation of the Nipro Elisio™ DialyzerCompletedNCT01653808Not applicable
- Development of a 'Phosphate Counting Program'Status unknownNCT01643486Not applicable
- The Effect of Thiazide, Amiloride and Hypertonic Saline on Urinary Biomarkers in Healthy SubjectsCompletedNCT01635231Not applicable
- Development and Effects of a Structural Education Program in Adult Kidney Transplant RecipientsStatus unknownNCT01630824Not applicable
- KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease : A 10-year Longitudinal Cohort Study of the Chronic Kidney DiseaseStatus unknownNCT01630486
- Renal Effects of an Angiotensin Converting Enzyme Inhibitor in Adults With Chronic Kidney Disease of Uncertain AetiologyStatus unknownNCT01624064Phase 1/2
- Effect of Hypertonic Sodium Chloride on Urinary Biomarkers in Healthy Subjects and Patients With Chronic Kidney DiseaseCompletedNCT01623661Not applicable
- Continuous Renal Replacement Therapy in the Setting of Orthotopic Liver TransplantWithdrawnNCT01619449Not applicable
- Study of Lanreotide to Treat Polycystic Kidney DiseaseStatus unknownNCT01616927Phase 3